Meghan FitzGerald

Delta Advisory Board member

Meghan FitzGerald is a global healthcare strategist, investor, academic and author. She has worked in every domain of healthcare from front line patient care through the Fortune 500 while serving as an Adjunct Professor at Columbia University.

Currently Ms. FitzGerald is a private equity investor where she serves as an advisor to several firms. Recently she was the CEO and Managing Partner at Letter One’s inaugural health vehicle allocating $4 billion in three years within pharma services and animal health. Prior to this Ms. FitzGerald spent nearly 20 years in Corporate America as an operator and strategist working for many prominent healthcare firms including Merck, Pfizer and Medco. Before transitioning out of corporate America, she was the EVP of Strategy, M&A and Health Policy at Cardinal Health (CAH) and a member of the Executive Committee. She is a member of the Board of Directors at Tenet Healthcare (THC) a Fortune 200 healthcare services company and is the founder of K2HealthVentures a life science investment fund. Ms. FitzGerald earned her Bachelor of Nursing from Fairfield University, her Masters of Public Health from Columbia University and her Doctor of Public Health (DrPH) at New York Medical College, focusing on health policy and the social determinants of health.